Compile Data Set for Download or QSAR
maximum 50k data
Found 55 with Last Name = 'mischki' and Initial = 't'
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50299565((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl...)
Affinity DataIC50:  1.60nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataIC50:  2.5nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451118(CHEMBL2114978)
Affinity DataIC50:  3.80nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084988((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  4.90nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451126(CHEMBL2114977)
Affinity DataIC50:  5.80nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084991((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  11nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451125(CHEMBL2114982)
Affinity DataIC50:  12nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451123(CHEMBL2114980)
Affinity DataIC50:  13nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084989((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  14nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084993((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  53nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451119(CHEMBL2115427)
Affinity DataIC50:  82nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451121(CHEMBL2115429)
Affinity DataIC50:  122nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084989((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  142nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084995((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  236nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451122(CHEMBL2115430)
Affinity DataIC50:  571nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451118(CHEMBL2114978)
Affinity DataIC50:  587nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451123(CHEMBL2114980)
Affinity DataIC50:  635nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50299565((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl...)
Affinity DataIC50:  894nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451127(CHEMBL2114986)
Affinity DataIC50:  1.08E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451126(CHEMBL2114977)
Affinity DataIC50:  1.14E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084990((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  1.16E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451127(CHEMBL2114986)
Affinity DataIC50:  1.24E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084983((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  1.52E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataIC50:  1.67E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451121(CHEMBL2115429)
Affinity DataIC50:  1.94E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084995((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  2.16E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084991((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  2.28E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084993((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  2.44E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDelta-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084994((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  2.54E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084988((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  2.65E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084989((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  2.73E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451125(CHEMBL2114982)
Affinity DataIC50:  2.87E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084983((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  4.64E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451123(CHEMBL2114980)
Affinity DataIC50:  5.74E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084990((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  7.22E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451118(CHEMBL2114978)
Affinity DataIC50:  7.56E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451120(CHEMBL2115434)
Affinity DataIC50:  8.13E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451122(CHEMBL2115430)
Affinity DataIC50:  8.24E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084991((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  9.00E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084995((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50:  9.29E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451125(CHEMBL2114982)
Affinity DataIC50:  9.44E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084983((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084994((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084993((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084994((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084990((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084988((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451126(CHEMBL2114977)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKappa-type opioid receptor(Homo sapiens (Human))
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451121(CHEMBL2115429)
Affinity DataIC50: >1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: